In a Race to Cure HIV : Gene Therapy, Vaccines and Other Approaches - Curetalks

In a Race to Cure HIV : Gene Therapy, Vaccines and Other Approaches

Progress in antiretroviral therapy has considerably reduced mortality and notably improved the quality of life of individuals infected with HIV . However, drug resistance, treatment-associated toxicity, adherence to medication, and the need for lifelong therapy have remained major challenges. While the development of an HIV vaccine has remained elusive, considerable progress in developing innovative cell and gene therapies to treat HIV infection has been made.

We are talking to Dr. Pablo Tebas M.D., Di­rector of the AIDS Clinical Trials Unit at University of Pennsylvania’s Center for AIDS Research (CFAR) on HIV gene therapies, vaccines, limitations of antiretroviral therapy (ART) and scope of new approaches for an HIV cure. 

Panelists

Talk Recorded on Nov 22, 2021, 09:00 am EST </> Embed
<iframe src="https://www.curetalks.com/event-embed/4236" id="frame" frameborder="0" scrolling="no" style="width: 100%; overflow: hidden; min-height: 500px;" ></iframe>

Submit a question for the panelists or leave a comment below.

Your email address will not be published. Required fields are marked *